Loading…
Insight Molecular Diagnostics Inc. is projected to rise to $5.43 by 2027, a +7% move from its current price of $5.08. IMDX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $4.84 | $5.08 | $5.33 | +0.05% |
| Jul 13 | $4.75 | $5.09 | $5.44 | +0.10% |
| Jul 14 | $4.68 | $5.09 | $5.53 | +0.16% |
| Jul 15 | $4.62 | $5.09 | $5.61 | +0.21% |
| Jul 16 | $4.57 | $5.09 | $5.67 | +0.26% |
| Jul 17 | $4.53 | $5.10 | $5.74 | +0.31% |
| Jul 18 | $4.49 | $5.10 | $5.79 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.49 | $5.10 | $5.79 | +0.37% |
| Week 2 | $4.27 | $5.12 | $6.13 | +0.73% |
| Week 3 | $4.12 | $5.14 | $6.41 | +1.10% |
| Week 4 | $3.99 | $5.15 | $6.66 | +1.47% |
| Week 5 | $3.89 | $5.17 | $6.89 | +1.85% |
| Week 6 | $3.80 | $5.19 | $7.10 | +2.22% |
| Week 7 | $3.72 | $5.21 | $7.31 | +2.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests.
Formerly OncoCyte Corporation, it changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.
Insight Molecular Diagnostics Inc. (IMDX) is a healthcare stock with a current price of $4.93 and a market cap of $159.19M. It is ranked 3983 by market capitalization. The stock trades within a 30-day range and displays near-term volatility in line with its size and sector exposure.
The 30-day trading range for IMDX is $3.51 to $6.93, indicating the near-term price corridor investors have observed recently. The stock’s 50-day and 200-day moving averages are around $5.45 and $5.36, respectively, providing a sense of near-term trend around the current level.
A major floor 49.8% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
The nearest ceiling, 28.9% above — a clean break opens room to run.
A major ceiling 42.4% above — clearing it would confirm fresh momentum.
Key IMDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.06 | Buy | $5.08 | Sell |
| MA 10 | $5.34 | Sell | $5.23 | Sell |
| MA 20 | $5.40 | Sell | $5.38 | Sell |
| MA 50 | $5.51 | Sell | $5.34 | Sell |
| MA 100 | $4.93 | Buy | $5.23 | Sell |
| MA 200 | $5.39 | Sell | $4.98 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.38 | Neutral |
| Stoch RSI (14) | 32.56 | Neutral |
| CCI (20) | -98.77 | Neutral |
| Williams %R (14) | -73.87 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -5.40 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 26.13 | Neutral |
| TRIX (15) | -0.14 | Sell |
| Awesome (5,34) | -0.61 | Sell |
| Ultimate (7,14,28) | 31.06 | Neutral |
| Momentum (10) | -0.51 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 4.69 | Buy |
| ADX (14) | 11.03 | Neutral |
| ATR (14) | 0.22 | Info |
The sentiment is NEUTRAL, with an RSI(14) of 40, suggesting neither overt oversold nor overbought conditions in the short term.
The stock’s near-term technicals show the 50-day moving average at $5.45 and the 200-day moving average at $5.36. Support is identified at $4.93 and resistance at $6.55, framing a shallow trading range for interactions around the current price. The 30-day range spans $3.51 to $6.93, and annualized volatility stands at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.55 | $5.08 | $7.37 | 0% | Neutral | |
| $4.01 | $5.43 | $7.92 | +7% | Neutral | |
| $4.36 | $6.22 | $9.63 | +23% | Bullish | |
| $5.46 | $8.16 | $13.22 | +61% | Bullish | |
| $7.04 | $10.96 | $18.43 | +116% | Bullish | |
| $7.38 | $11.94 | $20.72 | +135% | Bullish | |
| $6.53 | $10.96 | $19.58 | +116% | Bullish | |
| $7.23 | $12.57 | $23.05 | +147% | Bullish | |
| $7.41 | $13.31 | $24.98 | +162% | Bullish | |
| $8.07 | $14.98 | $28.74 | +195% | Bullish | |
| $9.32 | $20.25 | $42.46 | +299% | Bullish | |
| $23.40 | $51.99 | $119.57 | +923% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.55 | $5.08 | $6.15 | +0.00% |
| August 2026 | $4.13 | $4.98 | $6.24 | -1.97% |
| September 2026 | $4.36 | $5.33 | $6.80 | +6.99% |
| October 2026 | $4.60 | $5.68 | $7.37 | +6.63% |
| November 2026 | $4.48 | $5.58 | $7.33 | -1.78% |
| December 2026 | $4.41 | $5.54 | $7.37 | -0.72% |
Click any year to see its month-by-month IMDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, IMDX is projected to trade between $2.55 and $7.37, averaging $5.08 — a potential gain of 0% from today's $5.08. A consolidation phase looks the most probable path here.
Insight Molecular Diagnostics Inc.'s 2027 outlook centres on $5.43, within a $4.01 to $7.92 range. That is up +7% on the projected 2026 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2028, IMDX could reach as high as $9.63, with a base case around $6.22 and support toward $4.36 — roughly +23% from $5.08. Buyers look set to stay in control over this stretch.
Expect IMDX to range from $5.46 to $13.22 through 2029. The $8.16 average target implies a +61% move from current prices. That is up +31% on the projected 2028 average. Momentum favours further upside here.
The IMDX price prediction for 2030 points to an average of $10.96 (low $7.04, high $18.43) — a potential gain of +116% on today's $5.08. Buyers look set to stay in control over this stretch.
In 2031, IMDX is projected to trade between $7.38 and $20.72, averaging $11.94 — a potential gain of +135% from today's $5.08. That is up +9% on the projected 2030 average. Momentum favours further upside here.
Insight Molecular Diagnostics Inc.'s 2032 outlook centres on $10.96, within a $6.53 to $19.58 range. That is -8% versus the projected 2031 average. That marks a +116% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, IMDX could reach as high as $23.05, with a base case around $12.57 and support toward $7.23 — roughly +147% from $5.08. Momentum favours further upside here.
Expect IMDX to range from $7.41 to $24.98 through 2034. The $13.31 average target implies a +162% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The IMDX price prediction for 2035 points to an average of $14.98 (low $8.07, high $28.74) — a potential gain of +195% on today's $5.08. Momentum favours further upside here.
In 2040, IMDX is projected to trade between $9.32 and $42.46, averaging $20.25 — a potential gain of +299% from today's $5.08. That is up +35% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Insight Molecular Diagnostics Inc.'s 2050 outlook centres on $51.99, within a $23.40 to $119.57 range. That is up +157% on the projected 2040 average. That marks a +923% change versus current levels. Momentum favours further upside here.
Investing $1,000 in IMDX today (≈ 196.850394 IMDX) could be worth
$10,234.04
+$9,234.04 (+923%) by 2050 · US Dollar
Based on the average projected IMDX price of $51.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMDXwould be worth at today's price.
$1,000 invested in IMDX on Jul 10, 2025 (≈ 346.020749 IMDX) would be worth
$1,757.79
+$757.79 (+75.8%) today · 1.76× · US Dollar
Based on a IMDX entry price of $2.89 vs. today's $5.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.74 | $885.02 | -11.5% |
| 1 month ago | $5.76 | $881.94 | -11.8% |
| 3 months ago | $3.17 | $1,602.52 | +60.3% |
| 6 months ago | $7.11 | $714.49 | -28.6% |
| 1 year ago | $2.89 | $1,757.79 | +75.8% |
| All time (5.0y) ago | $115.2 | $44.1 | -95.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMDX forecast.
Our base-case forecast reaches $10.00 around 2030.
Implied market cap at $10.00: $322.9M
The multi-year forecast shows a path of rising averages with notable upside potential in later years. For 2026 the min is $2.55, the avg is $4.93, the max is $7.15, with ROI 0 and sentiment NEUTRAL.
In 2027 the min is $3.66, the avg is $5.01, the max is $7.42, with ROI 1.6 and sentiment NEUTRAL. The 2028 forecast includes a min of $3.79, an avg of $5.50, and a max of $8.65, with ROI 11.5 and sentiment NEUTRAL. The 2029 outlook shows a min of $4.63, an avg of $7.07, and a max of $11.67, with ROI 43.4 and sentiment BULLISH.
The 2030 forecast presents a min of $5.96, an avg of $9.52, and a max of $16.34, with ROI 93.1 and sentiment BULLISH; 2031 projects a min of $6.14, an avg of $10.22, and a max of $18.15, with ROI 107.3 and sentiment BULLISH. For 2032 the min is $5.35, the avg is $9.28, and the max is $16.97, with ROI 88.2 and sentiment BULLISH; 2033 shows a min of $5.79, an avg of $10.43, and a max of $19.60, with ROI 111.6 and sentiment BULLISH; 2034 has min $5.69, avg $10.63, max $20.48, ROI 115.7 and sentiment BULLISH; 2035 holds min $6.04, avg $11.71, max $23.07, ROI 137.6 and sentiment BULLISH.
Looking further out, the 2040 forecast shows a min of $6.83, an avg of $15.18, and a max of $32.80, with ROI 207.9 and sentiment BULLISH, while the 2050 forecast carries a min of $17.60, an avg of $39.11, and a max of $89.96, with ROI 693.4 and sentiment BULLISH. These are estimates and not guarantees, reflecting long‑term expectations for growth and adoption in a shifting healthcare diagnostics landscape.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg price of $9.52, a min of $5.96, and a max of $16.34, with ROI 93.1 and sentiment BULLISH.
The forecast shows a bullish trajectory in the later years, with 2029 avg $7.07 and 2030 avg $9.52, rising to 2040 avg $15.18 and 2050 avg $39.11, though early years show more modest upside and a 0–1.6 ROI. These are estimates, not guarantees.
Yes. The 2034 max is $20.48 and the 2035 max is $23.07, indicating scenarios where the price exceeds $20 under the forecast. The overall path remains subject to uncertainty.
The current price is $4.93 per share and the market cap is $159.19M. The rank is 3983.
The 30-day range is between $3.51 and $6.93.
Insight Molecular Diagnostics Inc. Community Discussion
0Share your Insight Molecular Diagnostics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.